SCHEMBL24199378

SCHEMBL24199378

CC(=O)c1c(C)c(=O)oc2ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.66
CA9 Q16790 3/20 0.66
KDM4E B2RXH2 4/20 0.62
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MAPT P10636 1/20 0.49
MAOB P27338 2/20 0.48
POLB P06746 1/20 0.48
VKORC1 Q9BQB6 2/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
CYP2C19 P33261 1/20 0.46
EYA3 Q99504 1/20 0.46
CYP1A2 P05177 1/20 0.46
NT5E P21589 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15842273 0.86 CA12 (0.75) CA12CA9KDM4EALDH1A1SMN1; SMN2
Acetic Acid SCHEMBL15653002 0.82 KDM4E (0.66) CA12CA9KDM4EALDH1A1SMN1; SMN2
SCHEMBL9657351 0.80 CYP2C19 (0.63) CA12CA9MAPTNPC1RAB9A
SCHEMBL24358817 0.80 CA12 (0.67) CA12CA9KDM4EALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL28525823 0.80 CA12 (0.62) CA12CA9KDM4EALDH1A1SMN1; SMN2
SCHEMBL3527681 0.79 CA12 (1.00) CA12CA9KDM4EALDH1A1SMN1; SMN2
SCHEMBL30933370 0.79 CA12 (1.00) CA12CA9KDM4EALDH1A1SMN1; SMN2
SCHEMBL2450078 0.79 KDM4E (0.71) CA12CA9KDM4EALDH1A1SMN1; SMN2
SCHEMBL27872231 0.79 HSD17B3 (0.71) CA12CA9KDM4EALDH1A1MAPT
SCHEMBL26339996 0.79 MAOA (0.53) CA12CA9KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225480-B2 Malic enzyme inhibitors SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225480-B2 Malic enzyme inhibitors ME1, RNASE1, ME2 CA12 315/4885CA9 72/4885KDM4E 821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.